SKIN
SkinHealth Systems Inc.
NasdaqCMUSDEQUITY
Consumer Defensive
DELAYED
Last price
0.67
▲ 0.04 (5.67%)
MARKET · —
Price
Open
0.62
Prev close
0.63
Day high
0.67
Day low
0.62
Volume
387.97K
Market cap
$85.02M
P/E (TTM)
—
52W range
0.55 – 2.69
Trailing performance
Returnvs SPY
1W
-2.10%
-0.7%
1M
-11.76%
-15.5%
3M
-1.06%
-4.2%
6M
-30.53%
-41.6%
YTD
-53.02%
-65.3%
1Y
-69.20%
-89.2%
3Y
-89.17%
-163.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$85.02M
Enterprise value$247.99M
Revenue (TTM)$290.05M
Gross profit$192.45M
EBITDA$20.08M
Net income$-28.43M
EPS (TTM)$-0.24
Free cash flow$27.48M
Total cash$204.07M
Total debt$367.04M
Book value / share$0.43
Shares outstanding130.14M
Float55.73M
Short % of float16.10%
Dividend yield—
Beta (5Y)1.00
Valuation & profitability ratios
Trailing P/E—
Forward P/E3.44
PEG ratio0.93
Price / sales—
Price / book1.53
EV / revenue0.86
EV / EBITDA12.35
Gross margin66.35%
Operating margin4.95%
Profit margin-9.80%
Return on equity-43.89%
Return on assets-0.54%
Debt / equity660.53
Current ratio1.76
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $300.80M | $334.30M | $398.00M | $365.88M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$9.50M | -$29.10M | -$100.10M | $44.38M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$9.50M | -$29.10M | -$100.10M | $44.38M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | — | 0.08 | — |
| Mar 2026 | — | 0.03 | — |
| Dec 2025 | -0.05 | -0.06 | -10.1% |
| Sep 2025 | -0.05 | 0.03 | +156.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.06 | 8 | $68.21M | -3.5% |
| Next quarter | -0.02 | 8 | $80.26M | -2.6% |
| Current year | -0.15 | 9 | $285.74M | -5.0% |
| Next year | 0.15 | 1 | $299.42M | +4.8% |
Analyst targets & ownership
Mean target$1.04
High target$1.50
Low target$0.85
Implied upside56.48%
Analyst count6
ConsensusHOLD
Strong buy / Buy0 / 1
Hold6
Sell / Strong sell0 / 2
Held by insiders13.03%
Held by institutions77.19%
Institutions holding124
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
16.96M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 20, 26 | MONAHAN MICHAEL P Chief Financial Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | MENEZES RONALD Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | LEWIS SHERI Chief Operating Officer |
STOCK | 746.68K | $0 | Direct |
| Mar 20, 26 | MALHA PEDRO BRUNO FERREIRA Chief Executive Officer |
STOCK | 2.65M | $0 | Direct |
| Nov 13, 25 | SCHAISON PHILIPPE Director |
STOCK | 57.69K | $0 | Direct |
| Oct 9, 25 | MALHA PEDRO BRUNO FERREIRA Chief Executive Officer |
STOCK | 2.19M | $3.42M | Direct |
| Jun 16, 25 | FANNING STEPHEN J Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | SAUNDERS BRENT L. Chairman of the Board |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | KERRICK MICHELLE C. Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | GRUBER DESIREE Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | SCHILLINGER DOUG K. Director |
STOCK | 73.05K | $0 | Direct |
| Jun 16, 25 | MILLER BRIAN CHRISTOPHER Director |
STOCK | 73.05K | $0 | Direct |
| Mar 17, 25 | MONAHAN MICHAEL P Chief Financial Officer |
STOCK | 639.20K | $843.75K | Direct |
| Mar 17, 25 | BECK MARLA MALCOLM Chief Executive Officer |
STOCK | 1.83M | $2.42M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BECK MARLA MALCOLM |
Chief Executive Officer | 2.85M | Stock Award(Grant) |
FANNING STEPHEN J |
Director | 527.28K | Stock Award(Grant) |
GRUBER DESIREE |
Director | 192.56K | Stock Award(Grant) |
LEWIS SHERI |
Chief Operating Officer | 1.61M | Stock Award(Grant) |
MALHA PEDRO BRUNO FERREIRA |
Chief Executive Officer | 4.85M | Stock Award(Grant) |
MENEZES RONALD |
Officer | 1.76M | Stock Award(Grant) |
MILLER BRIAN CHRISTOPHER |
Director | 243.03K | Stock Award(Grant) |
MONAHAN MICHAEL P |
Chief Financial Officer | 2.01M | Stock Award(Grant) |
SAUNDERS BRENT L. |
Chairman of the Board | 8.80M | Stock Award(Grant) |
SCHILLINGER DOUG K. |
Director | 216.03K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
0.64
+4.15% from price
SMA 20
0.67
-2.41% from price
SMA 50
0.73
-9.98% from price
SMA 100
0.76
-12.35% from price
SMA 200
1.03
-36.75% from price
EMA 12
0.65
+2.54% from price
EMA 26
0.68
-2.66% from price
EMA 50
0.72
-7.32% from price
RSI (14)
46.2
Neutral
MACD (12,26,9)
-0.03
Hist -0.00
ATR (14)
0.06
8.89% of price
Realised vol 30D
90.9%
Annualised
Bollinger upper
0.76
20, 2σ
Bollinger lower
0.58
20, 2σ
50 / 200 cross
Death
0.73 vs 1.03
Trend bias
Below 200
-36.75%
Risk profile
Beta vs SPY
1.35
More volatile than market
Correlation to SPY
0.18
Largely independent
Realised vol 30D
90.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-77.9%
Peak to trough
Max drawdown 5Y
-98.0%
Peak to trough
ATR 14
0.06
8.89% of price
Beta (reported)
1.00
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
0.50
-23.5% from spot
ATM implied vol
118.8%
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
22
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
1.00
66 contracts
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Merit Medical Announces Global Operations Leadership Transition
GlobeNewswire · 3d ago
SkinHealth Systems Inc. (SKIN) International Revenue Performance Explored
Zacks · 11d ago
Beauty Health Q2 Earnings Call Highlights
MarketBeat · 15d ago
The Beauty Health Company Q2 2026 Earnings Call Summary
Moby · 15d ago
SkinHealth Systems Inc (SKIN) (Q2 2026) Earnings Call Highlights: Strong EBITDA Beat and ...
GuruFocus.com · 15d ago
SkinHealth Systems Inc. (SKIN) Reports Q2 Earnings: What Key Metrics Have to Say
Zacks · 16d ago
SkinHealth Systems Inc. (SKIN) Reports Q2 Loss, Lags Revenue Estimates
Zacks · 16d ago
SkinHealth Systems Reports Second Quarter 2026 Financial Results
GlobeNewswire · 16d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.